Stock listing

Ucb S.a.

Selected listing: UNC · MUN · EUR · DE

Ucb S.a. (Munich:UNC), Health Technology. Latest release Sep 30, 2026: UCB : announces new data at EADV 2026 supporting earlier use of BIMZELX (bimekizumab)…

UNC:MUNEURDEUpdated October 3, 2026

Ticker: Munich:UNC
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

Latest news from Ucb S.a.

UCB : announces new data at EADV 2026 supporting earlier use of BIMZELX (bimekizumab) for treating hidradenitis suppurativa

September 30, 2026

UCB : data presented at 2026 AANEM Annual Meeting and MGFA Scientific Session underscore leadership in advancing targeted treatments for gMG

September 29, 2026

UCB : receives U.S. FDA Breakthrough Therapy Designation for CIMZIA (certolizumab pegol) in pregnant women with antiphospholipid syndrome (APS)

September 9, 2026

UCB Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S. Manufacturing

August 31, 2026

UCB : Transparency notification Wellington Management Group LLP

August 31, 2026

All Ucb S.a. news →

Research Ucb S.a.

Ucb S.a. company profile

View the public company page for Ucb S.a. on 6ix.

Ucb S.a. news

Read company news and market updates connected to Ucb S.a..

Ucb S.a. investor events

Find investor webinars, events, and replay context for Ucb S.a..